Presence of haptoglobin-2 allele is associated with worse functional outcomes after spontaneous intracerebral hemorrhage

World Neurosurgery

Volumn 83, Issue 4, 2015, Pages 583-587

  Murthy, Santosh B ^a   Levy, Andrew P ^c   Duckworth, Joshua ^a   Schneider, Eric B ^b   Shalom, Hadar ^c   Hanley, Daniel F ^a   Tamargo, Rafael J ^a   Nyquist, Paul A ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

Clinical outcomes; Haptoglobin phenotype; Intracerebral hemorrhage

Indexed keywords

HAPTOGLOBIN;

ADULT; ALLELE; ARTICLE; BRAIN HEMORRHAGE; CLINICAL TRIAL; COMORBIDITY; CONTROLLED STUDY; FEMALE; FUNCTIONAL ASSESSMENT; GENETIC MARKER; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PHENOTYPE; RANKIN SCALE; SUBARACHNOID HEMORRHAGE; TREATMENT OUTCOME; AGED; COHORT ANALYSIS; COMPLICATION; GENETICS; GLASGOW COMA SCALE; HYPERTENSION; INTRACRANIAL HEMORRHAGES; MIDDLE AGED; PROSPECTIVE STUDY; RISK FACTOR;

ADULT; AGED; ALLELES; COHORT STUDIES; FEMALE; GLASGOW COMA SCALE; HAPTOGLOBINS; HUMANS; HYPERTENSION; INTRACRANIAL HEMORRHAGES; MALE; MIDDLE AGED; PHENOTYPE; PROSPECTIVE STUDIES; RISK FACTORS; SUBARACHNOID HEMORRHAGE; TREATMENT OUTCOME;

EID: 84931034699     PISSN: 18788750     EISSN: 18788769     Source Type: Journal    
DOI: 10.1016/j.wneu.2014.12.013     Document Type: Review

References (19)

1. Azarov I, He X, Jeffers A, Basu S, Ucer B, Hantgan RR, Levy A, Kim-Shapiro DB: Rate of nitric oxide scavenging by hemoglobin bound to haptoglobin. Nitric Oxide 18:296-302, 2008.
2. Borsody M, Burke A, Coplin W, Miller-Lotan R, Levy A: Haptoglobin and the development of cerebral artery vasospasm after subarachnoid hemorrhage. Neurology 66:634-640, 2006.
3. Bowman BH, Kurosky A: Haptoglobin: The evolutionary product of duplication, unequal crossing over, and point mutation. Adv Hum Genet 12:189-261; 453-454, 1982.
4. Chaichana KL, Levy AP, Miller-Lotan R, Shakur S, Tamargo RJ: Haptoglobin 2-2 genotype determines chronic vasospasm after experimental subarachnoid hemorrhage. Stroke 38:3266-3271, 2007.
5. Davis SM, Broderick J, Hennerici M, Brun NC, Diringer MN, Mayer SA, Begtrup K, Steiner T;; Recombinant Activated Factor VII Intracerebral Hemorrhage Trial Investigators: Hematoma growth is a determinant of mortality and poor outcome after intracerebral hemorrhage. Neurology 66:1175-1181, 2006.
6. Hemphill JC 3rd, Bonovich DC, Besmertis L, Manley GT, Johnston SC: The ICH score: A simple, reliable grading scale for intracerebral hemorrhage. Stroke 32:891-897, 2001.
7. Hochberg I, Roguin A, Nikolsky E, Chanderashekhar PV, Cohen S, Levy AP: Haptoglobin phenotype and coronary artery collaterals in diabetic patients. Atherosclerosis 161:441-446, 2002.
8. Ijas P, Saksi J, Soinne L, Tuimala J, Jauhiainen M, Jula A, Kähönen M, Kesäniemi YA, Kovanen PT, Kaste M, Lindsberg PJ: Haptoglobin 2 allele associates with unstable carotid plaque and major cardiovascular events. Atherosclerosis 230:228-234, 2013.
9. Kantor E, Bayir H, Ren D, Provencio JJ, Watkins L, Crago E, Horowitz MB, Ferrell RE, Conley YP, Alexander SA: Haptoglobin genotype and functional outcome after aneurysmal subarachnoid hemorrhage. J Neurosurg 120:386-390, 2014.
10. Langlois MR, Delanghe JR: Biological and clinical significance of haptoglobin polymorphism in humans. Clin Chem 42:1589-1600, 1996.
11. Levy AP, Roguin A, Hochberg I, Herer P, Marsh S, Nakhoul FM, Skorecki K: Haptoglobin phenotype and vascular complications in patients with diabetes. N Engl J Med 343:969-970, 2000.
12. Ohnishi H, Iihara K, Kaku Y, Yamauchi K, Fukuda K, Nishimura K, Nakai M, Satow T, Nakajima N, Ikegawa M: Haptoglobin phenotype predicts cerebral vasospasm and clinical deterioration after aneurysmal subarachnoid hemorrhage. J Stroke Cerebrovasc Dis 22:520-526, 2013.
13. Pechlaner R, Kiechl S, Willeit P, Demetz E, Haun M, Weger S, Oberhollenzer F, Kronenberg F, Bonora E, Weiss G, Willeit J: Haptoglobin 2-2 genotype is not associated with cardiovascular risk in subjects with elevated glycohemoglobin-results from the Bruneck Study. J Am Heart Assoc 3:e000732, 2014.
14. Rother RP, Bell L, Hillmen P, Gladwin MT: The clinical sequelae of intravascular hemolysis and extracellular plasma hemoglobin: A novel mechanism of human disease. JAMA 293:1653-1662, 2005.
15. Vardi M, Blum S, Levy AP: Haptoglobin genotype and cardiovascular outcomes in diabetes mellitus- natural history of the disease and the effect of vitamin E treatment. Meta-analysis of the medical literature. Eur J Intern Med 23:628-632, 2012.
16. Vormittag R, Vukovich T, Mannhalter C, Minar E, Schönauer V, Bialonczyk C, Hirschl M, Pabinger I: Haptoglobin phenotype 2-2 as a potentially new risk factor for spontaneous venous thromboembolism. Haematologica 90:1557-1561, 2005.
17. Zazulia AR, Diringer MN, Derdeyn CP, Powers WJ: Progression of mass effect after intracerebral hemorrhage. Stroke 30:1167-1173, 1999.
18. Zhao X, Song S, Sun G, Strong R, Zhang J, Grotta JC, Aronowski J: Neuroprotective role of haptoglobin after intracerebral hemorrhage. J Neurosci 29:15819-15827, 2009.
19. Ziai WC: Hematology and inflammatory signaling of intracerebral hemorrhage. Stroke 44 (6 Suppl 1):S74-S78, 2013.